Stock data

慕康生醫 (5398)

慕康生醫 is a TPEx-listed company in Other. Revenue for September 2026 was NT$35.11M, up 39.0% from a year earlier. EPS over the last four quarters totals NT$0.10.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 慕康生醫 in Insightr